Dengue Tetravalent Vaccine from Germany
A chimeric live-attenuated tetravalent vaccine protecting against all four dengue virus serotypes for endemic prevention. Falls under HTS 3002.49.0050 as an 'other' vaccine for human prophylactic use, not matching specific viral listings. Developed through biotechnological recombination.
Duty Rate — Germany → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Secure FDA biologics import authorization; use validated -70°C shipping containers for live virus stability
• Label with serotype composition and expiration; submit CBER lot testing results pre-shipment